Studi clinici su Emicrania nello stato di Florida
12 studi su Emicrania cercano partecipanti presso sedi nello stato di Florida.
Città nello stato di Florida
Testo ufficiale dello studio (inglese)
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Direct Helpers Research Center, Hialeah
- D&H Tamarac Research Center LLC, Tamarac
- Santos Research Center, CORP, Tampa
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05156398Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- South Florida Research Phase I-IV, Inc, Miami
- Aqualane Clinical Research, Naples
- Clinical Associates of Orlando, LLC, Orlando
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- South Florida Research Phase I-IV, Inc, Miami
- Clinical Associates of Orlando, LLC, Orlando
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Northwest Florida Clinical Research Group, LLC /ID# 270833, Gulf Breeze
- My Preferred Research /ID# 270312, Miami
- Encore Medical Research - Weston /ID# 271139, Weston
- e altri 1
In reclutamentoFase 3
Età da 12 a 17 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Memorial Healthcare, Hollywood
- Mayo Clinic Florida, Jacksonville
- Apple Med Research, Miami
- e altri 1
In reclutamentoFase 4
Età da 18 a 70 · Tutti i sessi · Aggiornato il 16 set 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Encore Medical Research of Boynton Beach LLC /ID# 246833, Boynton Beach
- Gulf Coast Clinical Research Center /ID# 230020, Fort Myers
- AGA Clinical Trials /ID# 230554, Hialeah
- e altri 9
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT05125302Study of EVO756 in Adults With Migraine
- Clinical Neuroscience Solutions, Inc., Jacksonville
- Apple Medical Research Group, Inc, Miami
- Blessed Healthcase & Research, Miami
- e altri 4
In reclutamentoFase 2
Età da 18 a 64 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07616128Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Clinical Neuroscineces Solutions - Orlando, Orlando
- Clinical Neuroscineces Solutions, Orlando
In reclutamentoFase 2
Età da 18 a 65 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07646613A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- NW FL Clinical Research Group, LLC, Gulf Breeze
- AGA Clinical Trials - Hialeah - 4980 W 10th Ave, Hialeah
- University of South Florida, Tampa
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Homestead Associates in Research, Inc., Homestead
- Florida Neurology - Lake Mary, Lake Mary
- Flourish Research - Miami, LLC dba Flourish Research, Miami
- e altri 2
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 19 mag 2026 · NCT06602479Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
- University of Miami, Miller School of Medicine, Miami
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2025 · NCT07159750Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- Upsher-Smith Clinical Trial Site #14, Tampa
In reclutamentoFase 4
Età da 6 a 11 · Tutti i sessi · Aggiornato il 27 gen 2025 · NCT04748601Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.